Financial PerformanceMedtronic faces challenges such as inflation, higher labor costs, and higher material costs, which have led to a decline in net profits and profit margins.
Market CompetitionThe growing popularity of GLP-1 drugs could significantly impact Medtronic's insulin pump sales, with a risk of losing 50% of its market share.
Research And DevelopmentHigh interest rates may limit Medtronic's research and development capabilities, potentially delaying new product launches that could drive share price growth.